William E. Fitzsimmons

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Richard A. Nash, Joseph H. Antin, Chatchada Karanes et al. · PubMed · 2000 · 591 citations

Life Sciences, Hematology, Immunology +13

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka et al. · PubMed · 1998 · 568 citations

Life Sciences, Immunology, Pharmacology +16

Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report

Jon Kobashigawa, L.W. Miller, Stuart D. Russell et al. · American Journal of Transplantation · 2006 · 330 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATION

Ronald P. Kershner, William E. Fitzsimmons · Transplantation · 1996 · 309 citations

Medicine, Pharmacokinetics, Pharmacology +17

RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2

Christopher P. Johnson, Nasimul Ahsan, Thomas A. Gonwa et al. · Transplantation · 2000 · 296 citations

Pharmacy, Nephrology, Pharmacotherapy +17